After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured ...
Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing ...
A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...
Hepion Pharmaceuticals has had a turbulent year so far. With a YTD performance of -68.60%, its stock has struggled to gain traction in the market. This starkly contrasts with the broader market, as ...
A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage ...
We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient ...
9don MSN
Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial ...
The iDose platform is designed to address ubiquitous patient non-adherence and chronic side effects associated with topical ...
IGC Pharma, Inc (NYSE American:IGC) (”IGC” or the “Company”), today announced that CEO Ram Mukunda and CCO Claudia Grimaldi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback